Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 21411493)

1.

Strengthening the reporting of genetic risk prediction studies: the GRIPS statement.

Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; GRIPS Group.

BMJ. 2011 Mar 16;342:d631. doi: 10.1136/bmj.d631. No abstract available.

2.

Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement.

Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; GRIPS Group.

Genet Med. 2011 May;13(5):453-6. doi: 10.1097/GIM.0b013e318212fa82. No abstract available.

PMID:
21502867
3.

Strengthening the reporting of genetic risk prediction studies: the GRIPS statement.

Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; Human Genome Epidemiology Network.

Eur J Hum Genet. 2011 Aug;19(8):833-6. doi: 10.1038/ejhg.2011.25. Epub 2011 Mar 16.

4.

Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement.

Iglesias AI, Mihaescu R, Ioannidis JP, Khoury MJ, Little J, van Duijn CM, Janssens AC.

J Clin Epidemiol. 2014 May;67(5):487-99. doi: 10.1016/j.jclinepi.2013.10.006. Epub 2014 Jan 8. Review.

PMID:
24411311
5.

Ethical issues in the use of genetic markers in occupational epidemiologic research.

Schulte PA, Lomax GP, Ward EM, Colligan MJ.

J Occup Environ Med. 1999 Aug;41(8):639-46. Review.

PMID:
10457506
6.

Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement.

Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N.

Eur J Epidemiol. 2009;24(1):37-55. doi: 10.1007/s10654-008-9302-y. Epub 2009 Feb 3. Review.

7.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

Eur J Hum Genet. 2011 May;19(5):18 p preceding 494. doi: 10.1038/ejhg.2011.27.

8.

The family history as a tool to identify patients at risk for dilated cardiomyopathy.

Nauman D, Morales A, Cowan J, Dagua J, Hershberger RE.

Prog Cardiovasc Nurs. 2008 Winter;23(1):41-4. Review. No abstract available.

PMID:
18326985
9.

[Genetic polymorphism (sequence variation) of foreign substance-metabolizing enzymes and their significance in environmental medicine. Statement of the Commission "Methods and Quality Assurance in Environmental Medicine"].

Commission on Methods and Quality Assurance in Environmental Medicine.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Nov;47(11):1115-23. Review. German. No abstract available.

PMID:
15549207
10.

Recommendations for national and local regulatory authorities concerning research in genetic markers of disease.

Granger CB, Keavney B, Francomano C, Olsson G, Yusuf S.

Am Heart J. 2000 Oct;140(4):S3-5. Review. No abstract available.

PMID:
11011309
11.

Occupational and environmental health in the 21st century: the new frontier in genetics and disease prevention.

Rischitelli DG, Berman F, McCauley LA.

AAOHN J. 2005 Dec;53(12):522-8. Review.

PMID:
16401059
12.

[Guidelines on genetic research and genetic testing].

Fukushima Y.

Nihon Rinsho. 2005 Dec;63 Suppl 12:9-15. Review. Japanese. No abstract available.

PMID:
16416764
13.

Testing guidelines for hereditary non-polyposis colorectal cancer.

Umar A, Risinger JI, Hawk ET, Barrett JC.

Nat Rev Cancer. 2004 Feb;4(2):153-8. Review. No abstract available.

PMID:
14964310
14.

Genetic susceptibility to psychiatric disorders.

Conley YP, Steele AM, Puskar KR.

Medsurg Nurs. 2004 Oct;13(5):319-25. Review.

PMID:
15587131
15.

[Biological Markers in Epidemiology: Concepts, applications, Perspectives (Part II)].

Hoffmann W, Latza U, Ahrens W, Greiser KH, Kroke A, Nieters A, Schulze MB, Steiner M, Terschüren C, Wjst M.

Gesundheitswesen. 2002 Mar;64(3):145-52. Review. German.

PMID:
11904855
16.

Genetic advances in autism hinge on the method of measuring symptoms.

Todd RD.

Curr Psychiatry Rep. 2005 Apr;7(2):133-7. Review.

PMID:
15802090
17.

Informed consent in epidemiologic studies involving genetic markers.

Hunter D, Caporaso N.

Epidemiology. 1997 Sep;8(5):596-9. Review. No abstract available.

PMID:
9270965
18.

[Genetic susceptibility to infections].

Ott SJ, Schreiber S.

Internist (Berl). 2011 Sep;52(9):1053-4, 1056-8, 1060. doi: 10.1007/s00108-011-2858-8. Review. German.

PMID:
21842176
19.

The design, execution, and interpretation of genetic association studies to decipher complex diseases.

Romero R, Kuivaniemi H, Tromp G, Olson J.

Am J Obstet Gynecol. 2002 Nov;187(5):1299-312. Review.

PMID:
12439524
20.

A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research.

Willems SM, Mihaescu R, Sijbrands EJ, van Duijn CM, Janssens AC.

Curr Diab Rep. 2011 Dec;11(6):511-8. doi: 10.1007/s11892-011-0235-6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk